摘要
目的 探讨基质金属蛋白酶-2(MMP-2)和血管内皮生长因子(VEGF)在肾细胞癌组织中表达的临床意义.方法 选取70例肾细胞癌组织及同期30例正常肾脏组织,采用免疫组织化学方法检测MMP-2、VEGF的表达.结果 肾细胞癌组织中MMP-2和VEGF阳性表达率分别是65.71%和68.57%,且两者表达呈正相关(P<0.05).两者表达水平均与肿瘤病理分级及临床分期有关.结论 联合检测MMP-2与VEGF有助于反映肾细胞癌生物学行为.
Objective To explore the clinical significance of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) expression in renal cell carcinoma (RCC).Methods The immunohistochemistry staining method was used to evaluate the expression of MMP-2 and VEGF in 70 cases of RCC and 30 cases of normal renal tissue as controls.Results The expression of MMP-2 and VEGF was negatively correlated (P〈0.05),and their positive rate was 65.71% and 68.57% respectively.They were related to tumor pathological grade and clinical stage.Conclusion MMP-2 and VEGF are objective markers to estimate the behaviors of RCC.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2014年第12期2676-2677,共2页
Chinese Journal of Experimental Surgery
关键词
肾细胞癌
基质金属蛋白酶-2
血管内皮生长因子
生物学行为
Renal cell carcinoma
Matrix metalloproteinase-2
Vascular endothelial growthfactor
Biological behavior